Literature DB >> 10468606

A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA.

Q Waisfisz1, J P de Winter, F A Kruyt, J de Groot, L van der Weel, L M Dijkmans, Y Zhi, F Arwert, R J Scheper, H Youssoufian, M E Hoatlin, H Joenje.   

Abstract

Fanconi anemia (FA) is a recessively inherited disease characterized at the cellular level by spontaneous chromosomal instability and specific hypersensitivity to cross-linking agents. FA is genetically heterogeneous, comprising at least eight complementation groups (A-H). We report that the protein encoded by the gene mutated in complementation group G (FANCG) localizes to the cytoplasm and nucleus of the cell and assembles in a molecular complex with the FANCA protein, both in vivo and in vitro. Endogenous FANCA/FANCG complex was detected in both non-FA cells and in FA cells from groups D and E. By contrast, no complex was detected in specific cell lines belonging to groups A and G, whereas reduced levels were found in cells from groups B, C, F, and H. Wild-type levels of FANCA/FANCG complex were restored upon correction of the cellular phenotype by transfection or cell fusion experiments, suggesting that this complex is of functional significance in the FA pathway. These results indicate that the cellular FA phenotype can be connected to three biochemical subtypes based on the levels of FANCA/FANCG complex. Disruption of the complex may provide an experimental strategy for chemosensitization of neoplastic cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10468606      PMCID: PMC17886          DOI: 10.1073/pnas.96.18.10320

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Cytoplasmic localization of a functionally active Fanconi anemia group A-green fluorescent protein chimera in human 293 cells.

Authors:  F A Kruyt; Q Waisfisz; L M Dijkmans; M A Hermsen; H Youssoufian; F Arwert; H Joenje
Journal:  Blood       Date:  1997-11-01       Impact factor: 22.113

2.  The Fanconi anemia group C gene product is located in both the nucleus and cytoplasm of human cells.

Authors:  M E Hoatlin; T A Christianson; W W Keeble; A T Hammond; Y Zhi; M C Heinrich; P A Tower; G C Bagby
Journal:  Blood       Date:  1998-02-15       Impact factor: 22.113

3.  Evidence for at least eight Fanconi anemia genes.

Authors:  H Joenje; A B Oostra; M Wijker; F M di Summa; C G van Berkel; M A Rooimans; W Ebell; M van Weel; J C Pronk; M Buchwald; F Arwert
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

4.  The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex.

Authors:  G M Kupfer; D Näf; A Suliman; M Pulsipher; A D D'Andrea
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

5.  Mutations of the Fanconi anemia group A gene (FAA) in Italian patients.

Authors:  M Savino; L Ianzano; P Strippoli; U Ramenghi; A Arslanian; G P Bagnara; H Joenje; L Zelante; A Savoia
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

6.  Positional cloning of the Fanconi anaemia group A gene.

Authors: 
Journal:  Nat Genet       Date:  1996-11       Impact factor: 38.330

7.  Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase.

Authors:  F A Kruyt; T Hoshino; J M Liu; P Joseph; A K Jaiswal; H Youssoufian
Journal:  Blood       Date:  1998-11-01       Impact factor: 22.113

8.  Functional activity of the fanconi anemia protein FAA requires FAC binding and nuclear localization.

Authors:  D Näf; G M Kupfer; A Suliman; K Lambert; A D D'Andrea
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

9.  The Fanconi anemia proteins FAA and FAC function in different cellular compartments to protect against cross-linking agent cytotoxicity.

Authors:  F A Kruyt; H Youssoufian
Journal:  Blood       Date:  1998-10-01       Impact factor: 22.113

10.  Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA.

Authors:  J R Lo Ten Foe; M A Rooimans; L Bosnoyan-Collins; N Alon; M Wijker; L Parker; J Lightfoot; M Carreau; D F Callen; A Savoia; N C Cheng; C G van Berkel; M H Strunk; J J Gille; G Pals; F A Kruyt; J C Pronk; F Arwert; M Buchwald; H Joenje
Journal:  Nat Genet       Date:  1996-11       Impact factor: 38.330

View more
  31 in total

1.  Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A.

Authors:  H Joenje; M Levitus; Q Waisfisz; A D'Andrea; I Garcia-Higuera; T Pearson; C G van Berkel; M A Rooimans; N Morgan; C G Mathew; F Arwert
Journal:  Am J Hum Genet       Date:  2000-08-08       Impact factor: 11.025

2.  FANCE: the link between Fanconi anaemia complex assembly and activity.

Authors:  Paul Pace; Mark Johnson; Wu Meng Tan; Georgina Mosedale; Chelvin Sng; Maureen Hoatlin; Johan de Winter; Hans Joenje; Fanni Gergely; K J Patel
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

3.  A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome.

Authors:  Amom Ruhikanta Meetei; Salvatore Sechi; Michael Wallisch; Dafeng Yang; Mary K Young; Hans Joenje; Maureen E Hoatlin; Weidong Wang
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

Review 4.  Fanconi anaemia.

Authors:  M D Tischkowitz; S V Hodgson
Journal:  J Med Genet       Date:  2003-01       Impact factor: 6.318

5.  FAAP20: a novel ubiquitin-binding FA nuclear core-complex protein required for functional integrity of the FA-BRCA DNA repair pathway.

Authors:  Abdullah Mahmood Ali; Arun Pradhan; Thiyam Ramsingh Singh; Changhu Du; Jie Li; Kebola Wahengbam; Elke Grassman; Arleen D Auerbach; Qishen Pang; Amom Ruhikanta Meetei
Journal:  Blood       Date:  2012-02-17       Impact factor: 22.113

6.  FRG1P-mediated aggregation of proteins involved in pre-mRNA processing.

Authors:  Silvana van Koningsbruggen; Kirsten R Straasheijm; Ellen Sterrenburg; Natascha de Graaf; Hans G Dauwerse; Rune R Frants; Silvère M van der Maarel
Journal:  Chromosoma       Date:  2006-11-14       Impact factor: 4.316

7.  Evidence for subcomplexes in the Fanconi anemia pathway.

Authors:  Annette L Medhurst; El Houari Laghmani; Jurgen Steltenpool; Miriam Ferrer; Chantal Fontaine; Jan de Groot; Martin A Rooimans; Rik J Scheper; Amom Ruhikanta Meetei; Weidong Wang; Hans Joenje; Johan P de Winter
Journal:  Blood       Date:  2006-05-23       Impact factor: 22.113

8.  FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway.

Authors:  Chen Ling; Masamichi Ishiai; Abdullah Mahmood Ali; Annette L Medhurst; Kornelia Neveling; Reinhard Kalb; Zhijiang Yan; Yutong Xue; Anneke B Oostra; Arleen D Auerbach; Maureen E Hoatlin; Detlev Schindler; Hans Joenje; Johan P de Winter; Minoru Takata; Amom Ruhikanta Meetei; Weidong Wang
Journal:  EMBO J       Date:  2007-03-29       Impact factor: 11.598

9.  BLM and the FANC proteins collaborate in a common pathway in response to stalled replication forks.

Authors:  Pietro Pichierri; Annapaola Franchitto; Filippo Rosselli
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

10.  The cellular phenotype of Roberts syndrome fibroblasts as revealed by ectopic expression of ESCO2.

Authors:  Petra van der Lelij; Barbara C Godthelp; Wouter van Zon; Djoke van Gosliga; Anneke B Oostra; Jûrgen Steltenpool; Jan de Groot; Rik J Scheper; Rob M Wolthuis; Quinten Waisfisz; Firouz Darroudi; Hans Joenje; Johan P de Winter
Journal:  PLoS One       Date:  2009-09-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.